| Market revenue in 2024 | USD 235.2 million |
| Market revenue in 2030 | USD 497.3 million |
| Growth rate | 12.9% (CAGR from 2025 to 2030) |
| Largest segment | Glucose |
| Fastest growing segment | K+ |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | K+, Na+, Cl-, CO2, Glucose, BUN, Creatinine, Ca++, Albumin, Total Protein, ALP, ALT, AST, Total Bilirubin |
| Key market players worldwide | Abbott Laboratories, Quest Diagnostics Inc, Labcorp Holdings Inc, Sonic Healthcare Ltd, Alere, SYNLAB Group, ARUP Laboratories, Genoptix, Nova Medical Equipment |
Publish Date: Jan 17, 2025
Last Updated: Aug 26, 2026
No credit card required*
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| Quest Diagnostics Inc | View profile | 48,000 | 500 Plaza Drive, Secaucus, NJ, United States, 07094 | www.questdiagnostics.com |
| Labcorp Holdings Inc | View profile | 67,000 | 358 South Main Street, Burlington, NC, United States, 27215 | www.labcorp.com |
| SYNLAB Group | View profile | 1001-5000 | Manchester, Manchester, United Kingdom, Europe | www.synlab.co.uk/ |
| ARUP Laboratories | View profile | 1001-5000 | Salt Lake City, Utah, United States, North America | www.aruplab.com |
| Sonic Healthcare Ltd | View profile | 41,000 | 225 George Street, Level 22, Grosvenor Place, Sydney, NSW, Australia, 2000 | www.sonichealthcare.com |
| Nova Medical Equipment | View profile | - | Austin, Texas, United States, North America | novamedicalequipment.com |
| Alere | View profile | 5001-10000 | Waltham, Massachusetts, United States, North America | www.alere.com |
| Genoptix | View profile | 501-1000 | Carlsbad, California, United States, North America | www.genoptix.com/ |
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Comprehensive Metabolic Panel Testing Market Outlook will help companies and investors design strategic landscapes.
Glucose was the largest segment with a revenue share of 12.71% in 2024.
Horizon Databook has segmented the India comprehensive metabolic panel testing market based on k+, na+, cl-, co2, glucose, bun, creatinine, ca++, albumin, total protein, alp, alt, ast, total bilirubin covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the India comprehensive metabolic panel cmp testing market, including forecasts for subscribers. This country databook contains high-level insights into India comprehensive metabolic panel cmp testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
